TRAW Traws Pharma, Inc.

NEUTRAL Impact: 3/10 8-K
Horizon days Filed May 26, 2026 Processed 17d 17h ago SEC 0001104659-26-066345
8-K context-dependent: Items 8.01
Latest settled — T+5d ⚠ clustered
TRAW ▼ -5.23% at T+5d
NEUTRAL call ✗ call lost -5.23% · α vs SPY -5.70% · entry $1.53 → $1.45
Next anchor: T+20d in 11d
Currently $1.28 · -16.34% from $1.53 entry
Entry anchored
May 26, 2026
via day open
T+1d
-0.65%
call -0.65% · α -1.21%
$1.52
settled 17d ago
T+5d
-5.23%
call -5.23% · α -5.70%
$1.45
settled 11d ago
T+20d
call — · α —
in 11d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Traws Pharma filed an 8-K to update its at-the-market (ATM) offering program, supplementing its existing $50M ATM agreement with Citizens JMP Securities to allow sales of up to $3,128,399 in common stock under the company's current 'baby shelf' limitation. This is a routine administrative update to an existing equity facility, not a new capital raise, and does not provide any financial results or operational updates.

Actionable Insight

This is a routine shelf update with no immediate trading catalyst. Monitor future 8-Ks or prospectus supplements for actual ATM sales, which would indicate dilution. The $3.1M baby shelf limit represents ~13% of the current $23M market cap, so any material drawdown would be notable.

Key Facts

  • Traws Pharma filed a prospectus supplement dated May 22, 2026 under its existing ATM Agreement with Citizens JMP Securities.
  • The supplement authorizes sales of up to $3,128,399 in common stock, which is the company's current 'baby shelf' limitation under General Instruction I.B.6. of Form S-3.
  • The original ATM Agreement was entered into on March 10, 2025 and allows aggregate sales of up to $50,000,000.
  • No shares were reported as sold in this filing; the supplement merely updates the available capacity under the shelf.
  • The filing includes a legal opinion from Snell & Wilmer L.L.P. regarding the validity of the shares.

Financial Impact

Up to $3,128,399 in potential equity issuance under the existing ATM facility; no actual sales reported.

dilutionequity

Risk Factors

  • Potential dilution if the company actively sells shares under the ATM facility.
  • No operational or financial updates provided in this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-066345
Document: tm2615554d1_ex5-1.htm0001104659-26-066345
Document: 0001104659-26-066345-index-headers.html0001104659-26-066345
Document: 0001104659-26-066345-index.html0001104659-26-066345
Document: 0001104659-26-066345.txt0001104659-26-066345
14 reports for TRAW
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+20▲ +42.15%Apr 15, 2026
Filters
Rows
Reports for TRAW — sortable, filterable
Type Now
Jun 12, 2026
today
8-K
BEARISH ★ 7/10
$1.29 awaiting T+5awaiting T+5$1.28 (+0.78%)
May 29, 2026
15d ago
DEFA14A
NEUTRAL ★ 3/10
$1.46 $1.45▼ −0.68%▼ −0.39%$1.28 (−12.33%)
May 27, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$1.53 $1.42▼ −7.19%▼ −8.40%$1.28 (−16.34%)
May 26, 2026
17d ago
8-K
NEUTRAL ★ 3/10
$1.53 $1.45▼ −5.23%▼ −5.70%$1.28 (−16.34%)
May 22, 2026
22d ago
424B5
BEARISH ★ 7/10
$1.49 $1.47▲ +1.34%▲ +3.02%$1.28 (+14.09%)
May 18, 2026
26d ago
EFFECT
BEARISH ★ 7/10
$1.76 $1.58▲ +10.23%▲ +11.85%$1.28 (+27.27%)
May 15, 2026
29d ago
8-K
BEARISH ★ 7/10
$1.88 $1.49▲ +20.74%▲ +21.71%$1.28 (+31.91%)
May 15, 2026
29d ago
Press Release
MIXED ★ 5/10
$1.88 $1.49▼ −20.74%▼ −21.71%$1.28 (−31.91%)
May 8, 2026
5w ago
S-3
BEARISH ★ 8/10
$2.02 $1.76▲ +12.87%▲ +12.79%$1.28 (+36.63%)
May 8, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$2.18 $1.63▼ −25.23%▼ −26.69%$1.28 (−41.28%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (46h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access